×
About 775 results

ALLMedicine™ Blastomycosis Center

Research & Reviews  222 results

Pulmonary Blastomycosis Imaging
https://emedicine.medscape.com/article/354067-overview

May 20th, 2022 - Practice Essentials Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi an...

Pulmonary Blastomycosis Imaging
http://emedicine.medscape.com/article/354067-overview

May 20th, 2022 - Practice Essentials Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi an...

Pulmonary Blastomycosis Imaging
https://emedicine.medscape.com/article/354067-print

May 20th, 2022 - Blastomyces dermatitidis is a thermally dimorphic fungus that causes the systemic pyogranulomatous disease termed blastomycosis. This pathogen is endemic to North America, particularly in the states bordering the Mississippi and Ohio rivers, the G...

North American Endemic Fungal Infections.
https://doi.org/10.1016/j.rcl.2022.01.007
Radiologic Clinics of North America; Kanne JP

May 10th, 2022 - Histoplasmosis, blastomycosis, and coccidioidomycosis are endemic fungal infections in North America. Many infections are subclinical, and many symptomatic infections are mild. Pneumonia is the most common clinical manifestation. All can occur in ...

see more →

Guidelines  1 results

Clinical practice guidelines for the management of blastomycosis: 2008 update by the In...
https://doi.org/10.1086/588300
Clinical Infectious Diseases : an Official Publication Of... Chapman SW, Dismukes WE et. al.

May 9th, 2008 - Evidence-based guidelines for the management of patients with blastomycosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous management guidelines published in the April ...

see more →

Drugs  50 results see all →

Clinicaltrials.gov  5 results

Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
https://clinicaltrials.gov/ct2/show/NCT02283905

Sep 29th, 2020 - To evaluate six intensively studied patients admitted to medical intensive care with pulmonary blastomycosis requiring mechanical ventilation. Interventionally, all patients will receive continuously infused amphotericin-B (1 mg/kg/d); and then st...

Evaluation of the Association of Polymorphisms in the Innate Immune System With the Risk for Blastomycosis Dermatitidis Infection in Patients Not Infected With HIV and Complications Associated With...
https://clinicaltrials.gov/ct2/show/NCT00001702

Jul 2nd, 2017 - Innate immunity plays an important role for fungal recognition and initiation of fungicidal activity. We hypothesize that subtle differences in different molecules of innate immunity may contribute to either the predisposition or clinical course o...

Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis
https://clinicaltrials.gov/ct2/show/NCT00004811

Jun 9th, 2006 - PROTOCOL OUTLINE: This is a study to estimate the optimal dose of oral itraconazole. Patients are treated at 1 of 3 doses of itraconazole; the starting dose for each patient is determined at entry. Therapy is administered daily for 3-6 months. Pat...

Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
https://clinicaltrials.gov/ct2/show/NCT00004808

Jun 9th, 2006 - PROTOCOL OUTLINE: This is a randomized study. Patients are stratified by participating institution and type of infection. Patients with blastomycosis are randomly assigned to moderate- versus high-dose oral fluconazole. Based on clinical response,...

A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients...
https://clinicaltrials.gov/ct2/show/NCT00002159

Jun 24th, 2005 - Patients are randomized to receive IV itraconazole for 2 days, then either itraconazole daily for 5 days or amphotericin B daily for 7 days. IV treatment is followed by consolidation with oral itraconazole for up to 1 year.

see more →

News  32 results

Expanding Verrucous Plaque on the Face
https://www.mdedge.com/dermatology/article/234308/infectious-diseases/expanding-verrucous-plaque-face
Alyssa Miceli, DO, Ann Church, MD et. al.

Jan 7th, 2021 - The Diagnosis: Blastomycosis Histopathologic examination of 3 punch biopsies from the left side of the upper lip showed pseudoepitheliomatous hyperplasia with intraepidermal microabscesses and dermal suppurative granulomatous inflammation (Figure.

Exploring the Role of BTK Inhibitors in B-Cell Lymphomas
https://www.onclive.com/view/exploring-the-role-of-btk-inhibitors-in-bcell-lymphomas

Dec 5th, 2020 - Constantine S. Tam, MD On December 5, 2019, an OncLive® Scientific Interchange, Bruton Tyrosine Kinase Inhibitors in B-Cell Lymphomas took place in Orlando, Florida. The goal of the interchange, facilitated by Constantine S. Tam, MBBS, MD, an ass...

North American Blastomycosis in an Immunocompromised Patient
https://www.mdedge.com/dermatology/article/214767/infectious-diseases/north-american-blastomycosis-immunocompromised/page/0/1?channel=45

Dec 26th, 2019 - Punch biopsy from the upper back revealed a mixed acute and granulomatous infiltrate with numerous yeast forms (Figure 4A) that were highlighted by Grocott-Gomori methenamine-silver (Figure 4B) and periodic acid–Schiff (Figure 4C) stains. Figure 4.

North American Blastomycosis in an Immunocompromised Patient
https://www.mdedge.com/dermatology/article/214767/infectious-diseases/north-american-blastomycosis-immunocompromised
Mayha Patel, DO, Jeffrey K. Lander, MD, PhD

Dec 26th, 2019 - Blastomycosis is a systemic fungal infection that is endemic in the South Central, Midwest, and southeastern regions of the United States, as well as in provinces of Canada bordering the Great Lakes. After inhalation of Blastomyces dermatitidis sp.

Pediatric Primary Cutaneous Blastomycosis Clinically Responsive to Itraconazole
https://www.mdedge.com/dermatology/article/178659/pediatrics/pediatric-primary-cutaneous-blastomycosis-clinically
Isabelle M. Sanchez, MPH, Lorelei E. DiTommaso, MD, MPH et. al.

Nov 1st, 2018 - Blastomycosis is a polymorphic disease caused by the thermally dimorphic fungus Blastomyces dermatitidis, which is naturally occurring worldwide but particularly prominent in the Great Lakes, Mississippi, and Ohio River areas of the United States.

see more →